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Abstract: In recent years, we have witnessed to fast developments in the medicinal field of hydrogels 
containing various forms of integrated nanostructured carbon that adds interesting mechanical, ther-
mal, and electronic properties. Besides key advances in tissue engineering (especially for conductive 
tissue, such as for the brain and the heart), there has been innovation also in the area of drug delivery 
on-demand, with engineered hydrogels capable of repeated response to light, thermal, or electric stim-
uli. This mini-review focusses on the most promising developments as applied to the gelation of pro-
tein/peptide (including self-assembling amino acids and low-molecular-weight gelators), polysaccha-
ride, and/or synthetic polymer components in medicine. The emerging field of graphene-only hydro-
gels is also briefly discussed, to give the reader a full flavor of the rising new paradigms in medicine that are made possi-
ble through the integration of nanostructured carbon (e.g., carbon nanotubes, nanohorns, nanodiamonds, fullerene, etc.). 
Nanocarbons are offering great opportunities to bring on a revolution in therapy that the modern medicinal chemist needs 
to master, to realise their full potential into powerful therapeutic solutions for the patient. 
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1. INTRODUCTION 
Hydrogels are soft materials that retain a high level of 
water to find application in the medicinal field especially as 
absorption or release media, e.g., for tissue engineering, 
wound healing, drug delivery [1]. They can be made of a 
chemical or physical network of molecules, be it pro-
tein/peptides [2], polysaccharides [3], or synthetic polymers 
[4]. Incorporation of nanomaterials is a useful means to 
achieve unprecedented performance by adding new, interest-
ing features [5]. In particular, carbon nanostructures (e.g., 
single- or multi-wall carbon nanotubes or SWCNT/ 
MWCNT, graphene, carbon nanohorns, nanodiamonds, 
fullerenes, Fig. 1) add very interesting mechanical and elec-
tronic properties, thanks to their unique chemical structure 
[6]. However, there is always a certain level of concern for 
biological use of carbon nanostructures, as especially CNTs. 
First of all, the risk for their aggregation into asbestos-like 
pathogenic aggregates, although it is now known this is 
completely alleviated upon appropriate chemical functionali-
zation [7]. Other reasons for concern are: the risk for immu-
nogenic response, oxidative stress, and prolonged accumula-
tion in living tissue, thus eliciting inflammation or even 
more serious adverse reactions [8]. 
Nevertheless, there is a growing body of work showcas-
ing nanocarbon innovative potential in nanomedicine, espe-
cially upon appropriate chemical functionalization [9]. Be-
sides, in vitro studies on CNT-containing hydrogels evidence 
no sign of cytotoxicity on intestinal cells, showing promise 
for this class of materials [10]. CNT addition to hydrogels  
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opens the doors to “smart” biomaterials capable to respond 
to diverse stimuli, e.g., for drug release [11]. We will see that 
also graphene (G) is being increasingly studied to achieve 
similar properties, while other carbon nanoforms have only 
received limited interest in nanomedicine, thus far. 
This mini-review focusses on the latest exciting devel-
opments on this class of biomaterials, be it hybrid or com-
posites, for applications in the biomedical field. Due to the 
vast amount of literature on the topic, we will neither review 
the field of sensors, electrodes, actuators, nor will we attempt 
to give a comprehensive survey of the topic. 
By contrast, only the most promising and innovative 
studies for medicinal use of the last few years will be dis-
cussed, in an attempt to delineate the future directions of the 
field, and, especially, the high potential that can be realised 
in therapy thanks to the incorporation of carbon nanostruc-
tures. For instance, thanks to their high aspect ratio, CNTs 
offer the possibility to transport high levels of cargo (e.g., 
imaging agents, or drugs), as well as to be functionalized 
with antibodies to cap receptors for cell targeting (e.g., can-
cer cells) with subsequent CNT internalization and/or cell 
death, and, finally, to be rapidly eliminated via renal excre-
tion [12]. Therefore, it is apparent that carbon nanostructures 
open new doors to innovative therapy paradigms that were 
simply unthinkable a decade ago and that are moving at a 
fast pace [13].  
2. PROTEIN AND PEPTIDE HYDROGELS 
2.1. Protein Hydrogels 
Protein hydrogels are a plausible choice for biomaterials, 
thanks to their biocompatibility and biodegradability. They 
typically exploit the self-assembling ability of extracellular 
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matrix (ECM) components, such as collagens and gelatin [2]. 
However, they are often obtained from an animal source and 
display well-known issues of purification, immunogenicity, 
or even risk of pathogen transfer. Therefore, even though 
this is a mature field of research, protein hydrogels have 
been rarely admitted to clinical trials [2].  
Nevertheless, viscoelastic and biological properties of 
protein hydrogels make them stand out for medicinal use, 
and they are often used as components of more sophisticated 
biomaterials. In addition, amphiphilic proteins are well-
known to be good dispersants of hydrophobic nanocarbons, 
and their mutual interactions can be exploited to achieve 
advanced biomaterials [14]. Their combination with carbon 
nanostructures is a useful means to leverage their mechanical 
weakness, while adding conductive properties, thus extend-
ing their potential use to match the viscoelastic (and elec-
tronic properties) of different human tissues. SWCNTs can 
be used as a fibrous additive to 3D cell-seeded protein hy-
drogels to increase the electrical conductivity of such com-
posites [15]. 
For example, β-lactoglobulin is a gelling protein that it is 
widely used in the food industry [2]. It can form hybrids with 
MWCNTs to gel at protein concentrations that are notably 
lower than those required by the protein alone. Hybrids of 
similar nanomorphology are observed when the protein is 
bound via electrostatic interactions to either covalently, or 
non-covalently, sulfonated CNTs (Fig. 2) [16], suggesting a 
fibrillization promoting role played by the nanotubes, as seen 
in the case of the interaction between CNTs and amyloids 
[17]. Reversible gelation is possible thanks to the protein 
component, which gels at pH < pI (i.e., the protein isoelectric 
point) and flows at pH > pI, and the presence of CNTs in-
creases the gel elastic modulus [16].  
Silk fibroin is another gelling protein that has the advan-
tage of having a hydrophobic character to favourably interact 
with carbon nanostructures. Besides, thanks to its am-
phiphilic nature, the protein can establish hydrogen bonds 
with GO. As a result, silk fibroin forms composites with gra-
phene oxide (GO) to yield hydrogels of increased tensile 
strength, modulus, and failure strain, which thus display 
overall improved mechanical properties for their use as tis-
sue engineering scaffolds [18].  
In the case of engineered cardiac tissue, gelatin-SWCNT 
composite hydrogels can be prepared by mixing of the two 
components, followed by glutaraldehyde crosslinking. These 
biomaterials can integrate with host myocardium after im-
plant, and, remarkably, inhibit further pathological deteriora-
tion in an infarct model. Cells preferably adjoin SWCNTs 
throughout the infarct area, and show increased spontaneous 
activity (relative to the gelatin control) taking advantage of 
the CNT conductive properties [19]. 
In addition to tissue engineering scaffolds, also endovas-
cular stent devices can take advantage of CNTs. For in-
stance, a nanobiohybrid hydrogel-based vascular stent device 
can be engineered to promote endothelial recovery in a site-
specific manner, thanks to combined effects. A balloon-
expandable stent metal structure can be embedded in a fibrin 
hydrogel that is assembled layer-by-layer with intercalation 
of CNTs and nanoparticles carrying DNA (encoding for spe-
cific growth factors). In such a sophisticated design, the 
CNTs fine-tune the gel mechanical properties, while reduc-
ing loss of therapeutics away from the site of action, thanks 
to electrostatic interaction between the negatively-charged, 
polyacrylic acid-wrapped CNTs and the positively-charged, 
gene-carrying nanoparticles. Importantly, no inflammation is 
observed following in vivo stent application [20]. 
The combination of protein and carbon nanostructures 
into a hydrogel also allows to fine-tune the material proper-
ties by carefully balancing the amount of each component. 
For instance, hydrogels formed by soybean protein and GO 
present a porosity that is increased by the protein thanks to 
its hydrophilic character, thus ability to retain water [21]. 
These materials are interesting candidates for drug delivery, 
as shown by using the antibiotic ciprofloxacin as a model 
[21]. 
It is interesting to note that in some cases the interaction 
between carbon nanostructures and biological gel matrices 
can be detrimental for the mechanical properties of the latter, 
however, this behavior can be exploited for biomedical pur-
poses. In fact, it has been demonstrated that fullerene deriva-
tives, metallofullerol Gd@C82(OH)22, and the C60(OH)24 
analogue, are able to decrease the stiffness of collagen. The 
so-induced fragility of the biological system leads to de-
creased cell adhesion and viability, allowing envisaging a 
 
Fig. (1). Various forms of nanostructured carbon (for clarity, not to scale). 
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new use of these nanomaterials in the treatment of tumor 
tissues where the decreased rigidity of the extracellular ma-
trix, composted also by collagen, could end up with a slower 
metastasis process [22]. 
2.2. Polypeptide Hydrogels 
As mentioned in the section above, natural proteins pre-
sent some disadvantages for applications in the medicinal 
field, thus there is a certain research effort to substitute them 
with polypeptides of synthetic origin. Peptides allow for 
batch-to-batch high reproducibility in terms of chemical 
composition, and their chemistry is well-established and ver-
satile. In addition, their structure is more resilient relative to 
complex macromolecular proteins that require correct fold-
ing for function, and that are more sensitive to environment 
conditions [2]. Finally, amphiphilic peptides can effectively 
disperse and stabilize CNTs in aqueous solutions [14], and 
also in hydrogels [23], by establishing hydrophobic contacts 
with the nanostructure and exposing the hydrophilic portions 
for interaction with water. Therefore, instead of using full-
length gelling proteins, selected peptide fragments are often 
preferred. 
For instance, the silk fibroin-derived Gly-Ala-Gly-Ala-
Gly pentamer can be coupled to a GO-binding pyrene unit 
and a cross-linkable tyrosine residue (Fig. 3) to achieve an 
injectable “smart” hydrogel. This hybrid material has excel-
lent mechanical properties and recovers well, after repeated 
gel-disruptive cycles of applied strain. Thanks to the near-
infrared (NIR) responsive behavior of GO, it is possible to 
obtain on-demand drug release upon gel irradiation at 808 
nm, as the GO absorbs light, leading to a local temperature 
increase that reversibly unfolds the gel. Repeated cycles of 
doxorubicin drug release prove therapeutically effective in 
vivo against a tumor model in nude mice, while not showing 
signs of cytotoxicity arising from leaching of the gel compo-
nents [24]. 
Elastin-like polypeptides (ELPs) are a valuable class of 
hydrogelling agents owing to their thermoresponsive behav-
ior. At low temperature, ELPs adopt a random coil configu-
ration, while raising the temperature decreases the solubility 
and proteins aggregate into fibrillar structures. These proper-
ties, together with ease of production also by recombinant 
techniques, makes them popular vehicles for drug delivery 
and biomaterials [25]. Recombinant ELPs can be genetically 
encoded to be fused with other peptide motifs, for instance 
binding graphene, to combine the peptide thermo-behavior 
with graphene infrared photo-response, thus yielding smart 
hybrids with dual control [26]. 
A cyclic, hydrogel-forming decapeptide can been used to 
solubilize fullerene by means of ultra-high vibration ball 
milling, thus obtaining a water-soluble nanocomposite based 
on π-π interactions. Despite the fact that this complex 
changes the gelation properties of the peptide, since in the 
presence of C60 precipitation occurs, the proposed approach 
results to be very useful to prepare colloidal dispersions for 
biomedical uses [27]. 
2.3. Self-Assembling Ultra-Short Peptide Hydrogels 
Peptides are typically prepared by solid-phase methods, 
which offer advantages in terms of ease of purification, but 
at the expense of an elevated cost and solvent waste, which 
increase exponentially with peptide length. This is why for 
biomaterials and drug delivery use it is economically more 
viable to use ultrashort peptides, made of up to 3 amino ac-
ids, that can be prepared also by alternative methods [28, 
29]. The commercial potential of gelling, ultra-short peptides 
for medicinal use is evident from patent surveys [30]. Be-
sides, even single amino acids can yield hydrogels, given 
that they are functionalized with sufficiently hydrophobic 
moieties, such as fluorene derivatives, allowing for molecu-
lar stacking into ordered supramolecular structures. As an 
example, Fmoc-Phe forms hydrogels at physiological pH 
through the formation of π-π interactions between the aro-
matic units. Such interactions can be exploited also to incor-
porate sp2-carbon nanostructures into the soft material. With 
the aid of ultrasonication, oxidised SWCNTs can be dis-
persed and aligned with Fmoc-Phe nanofibers, to yield a 
hybrid hydrogel. The conductive material is more elastic and 
thermally stable than the gel made by the peptide alone, giv-
ing scope for use in medicinal applications [31]. Similarly, 
Fmoc-Phe-Asp-OH and Fmoc-Tyr-Asp-OH hydrogels are 
able to establish π-π interactions with rGO sheets, resulting 
in a nanohybrid material of enhanced rigidity [32]. A non-
covalent mechanochemical approach is also possible to dis-
perse and incorporate carbon nanostructures (including gra-
phene and fullerenes) into a self-assembled short peptide 
hydrogel [33]. 
 
Fig. (2). A) Schematic representation of the electrostatic interaction between functionalized MWCNTs and β-lactoglobulin. B-C) TEM im-
ages of hybrids formed with the protein and either covalently (B) or non-covalently (C) sulfonated MWCNTs. Adapted with permission from 
Ref. [16], Copyright © 2012, American Chemical Society. 
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Glutathione (GSH) is a tripeptide that is an interesting 
building block for biomaterials, considering its physiological 
role of free radicals scavenger. GO can be used as templating 
agent for the self-assembly and gelation of glutathione, 
through the formation of colloidal particles that stack into 
anisotropic fibers. Depending on conditions applied, differ-
ent nanomorphologies can be obtained for use in drug deliv-
ery, including bead-like structures (Fig. 4) arising from the 
self-scrolling of GO. Upon thermal treatment, the structures 
become hollow, although their morphology is preserved 
[34]. 
2.4. Future Directions of Protein/Peptide Hydrogels 
Proteins have historically been elected components to 
achieve hydrogel biomaterials, however, recent trends prefer 
peptide substitutes, thanks to their higher batch-to-batch re-
producibility and chemical resilience. Therefore, there is a 
notable research effort devoted towards the identification of 
peptide motifs with specific protein-mimicking function, and 
even more so, in the case of self-assembling low-molecular-
weight components. Since peptide production cost grows 
exponentially with its amino acid sequence length, a very 
recent research area focusses on di- and tri-peptides as eco-
nomically viable solutions for biomaterials [28]. 
Both proteins and peptides are well-known to favourably 
interact with nanostructured carbon to help its homogeneous 
dispersibility in aqueous media [14]. However, thus far, 
there are only limited studies on their combined use for hy-
drogel formation, especially for medicinal use. In light of the 
fast developments towards self-assembling short peptide 
hydrogels on one hand, and nanostructured carbon function-
alization for improved biocompatibility on the other, it is 
expected that their combined use will be the target of much 
more attention in near future studies. 
3. CARBOHYDRATE HYDROGELS 
Among the numerous macromolecules that can be used 
for hydrogels, polysaccharides are extremely advantageous, 
being widely present in living organisms and often being 
produced by recombinant DNA techniques. Coming from 
renewable sources, they typically offer an economical advan-
tage over synthetic polymers. Polysaccharides are generally 
well-tolerated in vivo and their physico-chemical properties 
make them suitable for many applications, spanning from 
tissue regeneration (particularly for cartilage), through drug 
delivery devices, to gel entrapment systems for the immobi-
lization of cells. In addition, they can be used also for target-
ing purposes, for instance, polysaccharide-wrapped CNTs 
can selectively deliver doxorubicin to cancer cells, exploiting 
 
Fig. (3). A) Silk fibroin-derived peptide sequence. B) Schematic representation of the gelling mechanism based on peptide self-assembly and 
tyrosine photo-crosslinking. Reproduced from Ref. [24] with permission of The Royal Society of Chemistry. 
 
Fig. (4). TEM images of GSH-GO hydrogels reveal a bead-like nanomorphology at both low (A) and high (B) magnification that is pre-
served after thermal treatment (C). Adapted from ref. [34] with permission from The Royal Society of Chemistry. 
The Glitter of Carbon Nanostructures in Hybrid/Composite Current Topics in Medicinal Chemistry, 2016, Vol. 16, No. 21    5 
chitosan to assist with CNT dispersibility, and hyaluronan to 
selectively target CD44 on cancer cells [35]. 
There are many polysaccharides used to form gel bioma-
terials. Chitosan, alginate, hyaluronic acid, cellulose, and 
agarose, are the most popular options (Fig. 5). However, 
hydrogels with improved mechanical properties are required 
during tissue regeneration to provide support and mechanical 
signaling to cells both in vitro and in vivo, for functional 
optimization of the new extracellular matrix being formed. 
In this context, functionalized water-soluble carbon nanos-
tructures can be very good candidates to reinforce the bio-
polymer hydrogels without altering their chemical proper-
ties. The interplay of the physical properties of CNTs with a 
biopolymer can give birth to a new generation of implants to 
reconstruct natural tissues that are subjected to high me-
chanical stress, or that require electrical and thermal conduc-
tivity at physiological state [36].  
Indeed, CNTs incorporated with biopolymers have 
shown great biocompatibility for orthopedic implants [37]. 
Graphene can also contribute to confer good electric and 
thermal conductivity, as well as mechanical stiffness [38]. At 
present, literature on graphene polymer nanocomposites for 
biomedical applications is still very scarce. 
Besides the use of the materials containing carbon nanos-
tructures, one has to consider their fate after expletion of the 
desired function. In general, polysaccharide-based hydrogels 
are mostly biodegradable and bioresorbable. On one hand, 
this is an advantage as in the case of drug delivery devices. 
On the other, it can become a drawback if the toxicity of the 
carbon nanomaterial itself is not well established or it is sub-
optimal. Nevertheless, in line of principle both the presence 
of the carbon nanomaterial, and the modified chemical na-
ture of the polymer to interact with it, will affect the degra-
dation profile of the hydrogel, and will likely increase the 
stability of the whole structure [39]. 
3.1. Chitosan Hydrogels 
Chitosan (CS) is one of the most common polysaccha-
rides that has been conjugated with carbon nanomaterials. 
One common approach is the covalent binding of CS amine 
groups with activated carboxylic functions of oxidized CNTs 
[40]. CS is a natural polysaccharide derived from chitin with 
a wide range of both current and potential applications in 
biology, medicine, and biotechnology [41]. In literature, 
there is a number of studies where CNTs have been inte-
grated into a CS matrix for several purposes. In general, the 
incorporation of CNTs into chitosan results in an improve-
ment of mechanical [42] and thermal [40] properties. Typi-
cally, these composites are aimed for tissue engineering, 
especially for bone [43], and cartilage tissue replacement, 
but also for nerve tissue reparation [44]. One of the major 
problems in the preparation of CS with CNT materials is the 
difficulty to disperse the CNTs in the polymer matrix. Sev-
eral methods have been used for this purpose, such as con-
trolled surface deposition and cross-linking [45], solution 
evaporation [46], thermally-induced phase separation fol-
lowed by freeze-drying [47], electrodeposition [48], layer-
by-layer spraying [49], pH and electrical actuation [50], and 
wet spinning [51].  
MWCNT–CS nanoparticle hybrids can be synthesized in 
situ through ionotropic gelation, which is an extremely mild 
process that involves the mixing of two aqueous solutions at 
room temperature. Under optimal conditions, CS nanoparti-
cles can be tethered to the MWCNT surface in high density 
and with relatively uniform coverage, yielding hybrids of 
good dispersibility and stability in aqueous solutions. The 
materials possess a higher BSA immobilization efficiency 
(77%), than MWCNTs alone (43%). It is expected that these 
hybrids may be used as biocompatible protein carriers, with 
potential applications as biomolecule delivery systems in 
gene/protein therapy [52]. Alternatively, gelatin can be used 
to facilitate CNT dispersion and achieve a homogeneous 
gelatin-chitosan-CNT hydrogel. The conductive material has 
great potential in cardiac tissue engineering; presence of 
SWCNTs increases cell electrical excitability and leads to 
the generation of more mature action potentials. In contrast 
with scaffolds suffering from poorly adjuncted cardiomyo-
cytes that generate arrhythmias, in this case cells infiltrate 
well the scaffold to nearly attain the natural heartbeat fre-
quency, giving hope for future use of the material to achieve 
myocardial patches [53].  
An interconnected network structure of organic–
inorganic scaffold can be attained also by other means, such 
as through the covalent linkage of the carboxyl group of 
functionalized carbon nanohorns, with the amine group of 
CS. The good dispersibility of functionalized nanostructured 
carbon and its ability to interact with the polar constituents 
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Fig. (5). Polysaccharides commonly used for hydrogels. 
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of cells and culture medium is an important physico-
chemical factor that influences cell interactions and biologi-
cal response. Furthermore, it is beneficial in promoting the 
biocompatibility and the degradation of the scaffold. The 
high water retention ability, the hydrophilic nature, and the 
interconnected porous structure of these scaffolds, facilitate 
cell attachment and proliferation, and enhance stability to-
ward enzymatic degradation [54]. 
Carboxylated nanodiamonds have also been exploited to 
engineer chitosan-derived “smart” nanogels and achieve pro-
longed drug release. In particular, functionalized nanodia-
monds are coated with polyethylene imine and then cross-
linked with acetylated CS to form nanogels that can be 
loaded with drugs. Next, contact lenses can be embedded 
with the nanogels, and subsequent contact with lacrimal fluid 
leads to lysozyme-mediated CS degradation and nanogel 
disassembly, and thus, sustained drug delivery. Notably, the 
engineered contact lenses display enhanced mechanical 
properties, while maintaining optical clarity, water content 
and oxygen permeability [55].  
In the case of graphene and GO as nanostructured carbon 
component, good dispersibility in water is easier to achieve. 
GO and CS can be used to form hybrid gels; additional CS 
functionalization with heparin improves hemocompatibility 
for use as absorbent for blood toxin removal. In this way, 
selective decontamination can be achieved, for instance by 
binding of bilirubin from blood samples [56]. Alternatively, 
reduced GO can also be well dispersed with CS, using lactic 
acid as a cross-linker to achieve a homogeneous composite 
with improved mechanical and conductive properties. The 
resulting hydrogel can be extrusion printed in 3D into scaf-
folds for tissue engineering, allowing infiltration of adherent 
cells (Fig. 6) [57]. 
CS porous scaffolds with GO 0.1 wt% and hydroxyapa-
tite nanoparticles were found more bioactive than neat CS, as 
the release of Ca and P ions was increased after soaking the 
nanocomposites in stimulated body fluid [58]. Similarly, Li 
et al. prepared CS/GO nanocomposites containing nano-
hydroxyapatite synthesized in situ, with improved mechani-
cal properties [59]. The nanocomposites exhibited a high cell 
proliferation rate, and the CS/GO/hydroxyapatite provided 
higher cell viability and alkaline phosphatase activity com-
pared to the GO/hydroxyapatite nanocomposite. 
Pinto et al. reviewed the biocompatibility of graphene 
nanocomposites and concluded that modification of GO with 
hydrophilic molecules or encapsulation in hydrophilic matri-
ces improves cell adhesion and compatibility [60]. The addi-
tion of 3 wt% GO in CS scaffolds improved the porosity by 
providing a better defined and well interconnected pore 
structure to the nanocomposites, without inducing significant 
cytotoxicity [61]. Cell attachment was found faster on gra-
phene/CS nanocomposite films with graphene content 0.1–
0.3 wt%, while displaying good biological safety and almost 
non-cytotoxicity [62]. 
CS-GO nanocomposite hydrogels find also applications 
in transdermal drug delivery as they allow for pH-sensitive 
release [63]. Besides, graphene and fullerene are useful nan-
ofillers to fine-tune the porosity of CS soft materials [64]. 
 
3.2. Alginate Hydrogels 
Alginate is an anionic, water-insoluble polysaccharide; 
its sodium salt gellifies in the presence of calcium ions, and 
this is the main method used for gelation also in the presence 
of other components, such as CNTs or graphene. Alginate 
hydrogels are successfully reinforced by SWCNTs that have 
been previously dispersed by means of polymer wrapping 
[65]. Multinozzle biopolymer deposition is an ideal method 
to build composite alginate/SWCNT scaffolds that allow for 
cell attachment and proliferation [66]. GO can be incorpo-
rated in alginate hydrogel fibers also by wet spinning 
through a CaCl2 coagulating bath. The addition of GO sig-
nificantly improves the strength of the fibers, which have 
similar water absorbency to alginate fibers in aqueous solu-
tion. Importantly, within a week of culture, rabbit transparent 
cartilage cells grow and spread on the gel [67]. 
Alginate-CNT conjugates can also be used for drug de-
livery in cancer therapy (Fig. 7). Oxidized SWCNTs can be 
wrapped by CS first, and alginate later, so that the two poly-
saccharides favourably interact with each other thanks to 
their opposed surface charges. The wrapped CNTs display 
improved solubility and stability in aqueous environments. 
Subsequent addition of doxorubicin, as cargo for the CNT, 
effectively yields an unconventional drug delivery system 
[68]. 
3.3. Hyaluronic Acid Hydrogels 
Hyaluronic acid (HA) is an important component of ex-
tracellular matrices and is widely used as interface with bio-
logical systems for tissue engineering, wound healing or 
drug delivery [69].  
Carboxylated SWCNTs can be efficiently dispersed in an 
aqueous solution of HA to yield a hybrid hydrogel by cross-
linking with divinyl sulfone. While both the native and hy-
brid gels display shear-thinning behavior, the SWCNT-
containing gel has improved viscoelasticity, thanks to the 
participation of the hydroxyl functionality on the SWCNT 
surface, to the cross-linking of HA by divinyl sulfone. How-
ever, high water uptake capacity of the native gel and the 
hybrid gel are almost unchanged even after wt%. SWCNT 
incorporation. Therefore, this kind of gels could find poten-
tial application in tissue engineering, due to unique proper-
ties in terms of water uptake capacity, and increased viscoe-
lasticity [70]. CNT-HA conjugate systems are also promising 
as innovative therapeutic solutions for cancer. HA targets the 
receptor CD44 of gastric cancer stem cells, facilitating endo-
cytosis of the CNTs and cell death [69]. 
Incorporation of GO in HA hydrogels is an interesting 
approach to increase the loading capacity towards hydropho-
bic drugs, such as doxorubicin [71]. HA−GO−Doxorubicin 
nanohybrid hydrogel was constructed by conjugating GO 
with HA via H-bond interaction for targeted delivery of 
doxorubicin to induce selective cytotoxicity in target cancer 
cells [72]. The as prepared hydrogel possessed excellent 
physiological stability, high drug loading capacity for DOX, 
pH responsiveness, and it allowed sustained release of anti-
cancer drugs selectively to target cells. This fact was demon-
strated by efficient inhibition of proliferation only of target 
cells, without side effects to controls. Moreover, an in vivo 
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anticancer efficacy study using a mouse model demonstrated 
higher tumor inhibition rate of HA−GO−DOX compared to 
free DOX and GO−DOX formulation at an equivalent drug 
dose. Overall, GO-HA biomaterials could provide interesting 
therapeutic solutions, especially if taking advantage of GO 
unique properties that could allow for cancer cell photother-
mal ablation based on NIR-response [73]. 
3.4. Cellulose Hydrogels 
The most abundant organic polymer on Earth, cellulose, 
is also a popular material for biomedical applications. Elec-
trospun cellulose acetate nanofibers can be assembled with 
positively charged chitosan, and negatively charged 
MWCNTs or sodium alginate, via layer-by-layer technique. 
The incorporation of MWCNTs in the multi-layered fibrous 
scaffolds tends to improve attachment, spreading, and prolif-
eration of mouse fibroblasts. With good protein adsorption 
capacity, mechanical durability, cell attachment and prolif-
eration, and good hemocompatibility, the MWCNT-
containing multi-layered composites should find applications 
in tissue engineering and regenerative medicine. The facile 
assembly approach may be extended to immobilize also 
other bioactive components for scaffold tailoring to a range 
of biomedical uses [74]. 
Cellulose, and more recently nanocellulose, are also be-
coming popular building blocks to achieve biologically be-
nign hydrogels; further addition of carbon nanostructures 
such as graphene and GO makes the composites electroac-
tive, thus expanding the breadth of potential applications 
[75]. Cellulose and GO can also yield highly porous hydro-
gel monoliths characterised by high adsorbing capacity and 
compressive strength [76]. 
GO–bacterial cellulose nanocomposite hydrogels with 
well-dispersed GO are successfully developed using a facile 
one-step in situ biosynthesis by adding GO suspension into 
the culture medium of bacterial cellulose [77]. The nano-
composites exhibit significantly higher tensile strength and 
modulus over pristine cellulose, owing to the uniform dis-
persion and interaction between GO and cellulose. Such hy-
drogels are promising as tissue engineering scaffolds. 
 
Fig. (6). Confocal microscopy stacked images at low (A) and high (B) magnification of reduced GO-CS composite hydrogel printed in 3D in 
a fibrous scaffold that allows adherent cell infiltration. Reprinted from Ref. [57], with permission of the Royal Society of Chemistry. 
 
Fig. (7). TEM images (top) and scheme (bottom) showing the assembly of polysaccharide-CNT-drug conjugates for cancer therapy. From 
left to right: CNT alone, CNT wrapped with alginate (A), CNT wrapped with A and chitosan (CS), and finally CNT-A-CS with added 
doxorubicin (DOX). Adapted from ref. [68], Copyright (2009), with permission from Elsevier. 
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Hyaluronic acid-fullerene conjugates have been proposed 
in photodynamic therapy, exploiting the C60 capability to 
generate 1O2 upon photoirradiation. Various derivatives 
demonstrated good capability of inhibiting cell proliferation 
in HCT-116 or MCF7 cell cultures and consequent tumor 
regression in in vivo experiments [78]. 
3.5. Agarose Hydrogels 
Agarose has the ability to disperse and accommodate 
CNTs, while maintaining thermo-responsive hydrogelation 
and the potential to be easily functionalized to introduce fur-
ther chemical groups. Fibers containing the two components 
are rigid and tough when dry, but exhibit mechanical proper-
ties compliant with brain tissue once hydrated. They have 
shown to be not only non-toxic, but also biocompatible, and 
biologically modifiable. These properties, along with their 
stable electrical conductance, provide a novel material with 
high potential for future neurophysiologic use. The gelling 
properties of agarose allow it to be easily molded into vari-
ous shapes with applications such as directed nerve repair 
and nerve guidance conduit [79].  
Agarose is also capable of acting as stabilizer and physi-
cal cross-linker for graphene-based hydrogels, which display 
remarkable stability against a variety of harsh chemical con-
ditions [80]. 
3.6. Future Directions of Polysaccharide Hydrogels 
Polysaccharide hydrogels have been developed over the 
years for biomaterial applications. In particular, chitosan has 
shown to have the required physico-chemical and biological 
properties to become a popular choice that can be easily 
functionalized and adapted to various uses in medicine. In 
recent years, there has been the growing tendency to com-
bine multiple components into scaffolds for improved per-
formance, also using more than one polysaccharide alto-
gether. Therefore, it is common to see chitosan in conjuga-
tion with other carbohydrates, such as alginate, or especially 
hyaluronic acid. The latter is indeed an elected choice for 
specific cell targeting, or, more generally, as external coating 
to interface with cells. In the case of hybrid or composite 
hydrogels, polysaccharides can also be combined with pro-
teins to assist with carbon nanostructure dispersibility, and it 
is expected that this trend to use different components in 
sophisticated biomaterial designs will perdure and be further 
refined in the future. The combination of multiple gelling 
agents with carbon nanostructures is a useful approach to 
control the material, and interesting properties can be ob-
tained, e.g., dual stimulus responsive drug release under the 
interaction of pH value and pulsatile electric field [81].  
4. SYNTHETIC POLYMER HYDROGELS 
4.1. Acrylate Polymers 
Acrylate polymers were the first components used to ob-
tain a hydrogel back in 1955 [4], and over the years they 
have been combined with other compounds, to achieve for-
mulations with enhanced properties for use as biomaterials. 
For instance, methacrylate hydrogels can be combined with 
GO and sodium styrene sulfonate polymers to mimic the 
carboxylate and sulfonate functional groups of heparin, re-
spectively (Fig. 8). The resulting materials display improved 
hemocompatibility, as expected from the heparin-mimicking 
function, revealing reduced platelet adhesion and anti-
coagulant property [82]. Their increased porosity and im-
proved swelling ability allows for drug loading and subse-
quent prolonged release [83]. 
Alternatively, the conjugation of cross-linkable 
methacrylate functional groups with gelatin protein leads to a 
low-modulus, biodegradable GelMA hydrogel [84]. Various 
applications can be envisaged for this versatile polymer, also 
in combination with nanostructured carbon, e.g. to increase 
mechanical resilience and electrical conductivity. Cell en-
capsulation can be attained within carboxylated MWCNT-
GelMA microgels that can be photo-patterned [85]. A simi-
lar concept makes use of GO combined with GelMA [86]. 
Gene therapy is another possible application, upon embed-
ding of polyethyleneimine-functionalized GO to form nano-
complexes with DNA. Inclusion of a pro-angiogenic VEGF-
encoding gene allows for transfection of myocardial tissue, 
and subsequent therapeutic effect on infarcted rat heart [87]. 
There are also other ways to achieve similar materials, for 
instance via functionalization of GO with methacrylate 
groups for subsequent copolymerization with GelMA into a 
soft material that allows fibroblast proliferation within a 7-
day period [88]. 
The (2-hydroxyethyl methacrylate) polymers, when pre-
pared in the presence of fullerene, change their properties, 
since the swelling ratio that results at equilibrium appears to 
be lower than that of the pristine hydrogel. This behavior is 
not surprising considering the hydrophobic character of the 
embedded molecules. This variation can be modulated, by 
changing the fullerene percentage content in order to obtain 
matrices with fine-tuneable release rate of drugs [89]. If de-
livery of bioactive fullerenes is desired, this can be achieved 
from microgels via swelling and shear-induced stress [90]. 
Combination the acrylate derivative poly(acryloyl-6-
aminocaproic acid with GO offer the possibility to combine 
higher mechanical resilience of the gel with self-healing, a 
property that is highly sought after, especially in tissue re-
generation [91]. Besides, addition of GO to pAA hydrogels 
offers the advantage of remarkably reducing the material 
brittleness [92]. Acrylate polymer composites bearing GO 
and antibacterial silver find applications in wound healing 
dressings [93]. When graphene is cross-linked to a 
poly(N,N-dimethylacrylamide) structure, the obtained hy-
drogel exhibits good neural compatibility, high conductivity, 
low impedance and efficient near-infrared-triggered pho-
tothermal self-healing behaviour [94].  
Among acrylate polymers, poly(N-isopropylacrylamide) 
(pNIPAAm) has gained widespread popularity thanks to its 
thermoresponsive behavior (Fig. 9). When the polymer is 
anchored on a surface and immersed in an aqueous solution, 
at room temperature it is in its extended, hydrated “brush” 
form, while upon mild heating to 32 °C and over, it collapses 
to its shrunk, dehydrated “mushroom” form. Cells can attach 
to pNIPAAm at 37 °C and detach at 20 °C to form a con-
tinuous layer or “cell sheet” for tissue engineering. In con-
trast to the limited potential of the polymer alone, anchorage-
dependent “cell sheets” can be prepared from MWCNT-
interpenetrated pNIPAAm hydrogels, thanks to the material 
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increased roughness and stiffness, allowing for appropriate 
cell spreading [95]. Similar effects are obtained with the in-
corporation of SWCNTs into pNIPAAm hydrogels [96]. 
Incorporation of GO into pNIPAAm hydrogels is also possi-
ble [97]. Alternatively, use of fullerene offers a means to 
tailor the material thermoresponse, by lowering the critical 
solution temperature thanks to the hydrophobic nature of C60 
[98]. 
Beside the thermo-sensitive behavior, gels can be engi-
neered also to respond to other external stimuli, thanks to the 
addition of the nanostructured carbon component. Incorpora-
tion of GO into a pNIPAAm hydrogel, previously function-
alized with an RGD peptide to promote cell adhesion [99], is 
a useful means to obtain a gel that, upon near-infrared (NIR) 
irradiation, shrinks to release cells [100]. The nanocarbons 
allow for also other, important, added benefits in the case of 
injectable tissue engineering of conducting organs. For in-
stance, engraftment and survival of stem cells is enhanced 
after their transplantation in infarcted myocardium, and even 
their therapeutic efficacy is improved [96]. Smart hydrogels 
can be engineered to respond to light also thanks to other 
photo-sensitive units. Host-guest supramolecular gels can be 
made by combining 1) a polysaccharide-cyclodextrin (i.e., 
the host) polymer used to wrap SWCNTs, thus favoring their 
dispersion in water, and 2) a pAA gelling polymer function-
alized with a photo-responsive azobenzene moiety (i.e., the 
guest). Reversible gel/sol transition is achieved upon UV/Vis 
irradiation, thanks to cis/trans isomerization of the azoben-
zene group, which thus gets out/in the cyclodextrin, respec-
tively [101].  
Incorporation of nanocarbons is a useful approach to 
fine-tune a material electro-response. As an example, pulsa-
tile drug delivery can be achieved by means of MWCNT 
[102] or graphene [103] incorporation into pMAA gels, and 
their subsequent de-swelling upon DC electric field stimula-
tion. MWCNTs that are covalently incorporated in acrylate-
derived hydrogel films serve the dual function of both en-
hancing the electro-responsivity and modulating the release 
of anionic and cationic drugs (e.g., diclofenac sodium salt 
and ciprofloxacin) [104]. Polymer electro-response can be 
used also in tissue engineering. Dielectrophoretically aligned 
MWCNTs within a GelMA matrix offer a useful template 
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Fig. (8). Heparin (top) sulfonate and carboxylate functional groups can be mimicked by a combination of sodium styrene sulfonate polymer 
(bottom left) and GO (bottom right), respectively [81]. 
 
Fig. (9). A) pNIPAAm chemical structure. B) pNIPAAm thermo-responsive behavior in aqueous solutions at cell-culture rele-
vant temperatures. 
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for hierarchical alignment of myoblasts and myotubes, in 
order to maximize contractility and force generation within 
engineered muscle tissue [105]. MWCNT-GelMA hybrid 
hydrogels are useful for cardiac tissue engineering, thanks to 
MWCNT ability to form collagen fibril-like nanofibers 
bridging gel pores, thus improving cardiomyocyte electrical 
coupling and allowing for spontaneous synchronous beating 
of thin cardiac patches [106]. 
Another example of stimuli-responsive CNT-hydrogel 
composite is offered by using a polyvinylpyrrolidinium posi-
tively charged matrix wrapping on CNTs, the counter ion of 
which is a Europium complex, emitting at 614 nm. In this 
case, the application of a magnetic field allows for the 
alignment of the tubes with a consequent anisotropic effect. 
Even though the biological application of this system is not 
straightforward, it may pave the way to the preparation of 
new theranostic devices [107]. 
4.2. Poly(Vinyl Alcohol) 
Poly(vinyl alcohol) (PVA) hydrogels are distinguished 
by their ability to retain water in their structure very well, 
and thus maintain a moist environment for longer periods, 
relative to other synthetic hydrogels [4]. Introduction of rGO 
in a PVA matrix is a useful means to obtain electro-
responsive hydrogels for pulsatile drug delivery in wound 
healing and transdermal therapy [108]. GO can also be cross-
linked by using 2,2′-(ethylenedioxy)-diethanethiol prior to 
incorporation into the PVA matrix. The resulting composite 
hydrogels have improved mechanical properties and sustain 
chondrocyte survival and proliferation [109]. When GO is 
used as a nanofiller for PVA hydrogels via a freeze-thaw 
method, the resulting material displays increased tensile and 
compressive strength, while not showing cytotoxicity to os-
teoblasts in vitro [110]. 
4.3. Poly(Ethylene Oxide)-Derived Polymers 
PEO, also known as poly(ethylene glycol) or PEG, is one 
of the most popular hydrogels for medicinal applications, 
thanks to its good biocompatibility that has been well-proven 
over the years in numerous examples [4]. Popular are also 
the derived PPO-copolymers, including the well-known 
Pluronics. Injectable hydrogels can be obtained from GO-
Pluronic mixtures that undergo sol/gel transitions through 
physical cross-linking, induced in response to a variety of 
convenient stimuli, including NIR irradiation, mild heating, 
and pH change [111]. Pluronic also provides an effective 
means to chemically exfoliate graphene, with the hydropho-
bic PPO units interacalating between graphene sheets, and 
the hydrophilic PEO chains extending in the surrounding 
aqueous environment [112]. Thanks to graphene, the result-
ing hybrid hydrogel presents a lamellar structure that allows 
for shear-thinning behaviour, which, together with the re-
duced viscosity and thermo-response, makes these hybrids 
interesting injectable candidates for drug delivery [112]. A 
recent report highlighted the possibility to crosslink PEO-
PPO copolymers with GO by means of peroxidase catalysis, 
yielding injectable and mechanically robust hydrogels [113]. 
PEG-diacrylate hydrogels, embedding nanodiamond-
daunorubicin complexes and temozolomide, demonstrate 
their capacity to slow down the release of antitumor drugs, 
avoiding the side effects due to massive and uncontrolled 
liberation of the active compounds, as it typically occurs 
during burst release. The prolonged delivery seems to be 
related to the presence of nanodiamonds, which provide a 
high surface for the loading of the drug. Moreover, the 
authors show how two-layered gel preparations can be de-
signed, for the sequential availability of, first, temozolomide 
released from the PEG-hydrogel, and, later, daunorubicin 
released from the nanodiamond-complexes, for applications 
in combined therapy [114].  
4.4. Future Directions for Synthetic Polymer Hydrogels 
 Among the many available options for synthetic 
polymer hydrogels, acrylate polymers have been probably 
the most studied, thanks to their efficient and well-known 
chemistry. However, the toxicity of acrylate monomers and 
of the other chemical components often used in the polym-
erization process is a high barrier for their effective imple-
mentation in novel solutions for medicinal use. By contrast, 
PEG derivatives have a more benign nature. They are al-
ready featured in many products currently present on the 
market, thus it is likely they will be receiving increasing at-
tention for the development of hybrid or composite hydrogel 
biomaterials. Their conjugation with CNTs has already been 
widely exploited for medicinal applications, although not yet 
for the development of PEG-based scaffolds, but rather to 
simply improve CNT dispersibility in water for the use as 
drug vectors. Therefore, the development of PEG-based 
scaffolds containing CNTs or graphene derivatives seems to 
likely be the next step in this fast-moving research area.  
5. GRAPHENE HYDROGELS 
There is a growing interest in developing a variety of 
biomaterials based on graphene and/or GO building blocks, 
as their properties make them promising candidates for inno-
vative applications in tissue engineering and bionics [115]. 
Moreover, graphene is a rising star also for drug delivery 
applications [116]. Although this 2D nanomaterial is a recent 
addition to the family of nanocarbons, its chemical modifica-
tion is already quite well-established, both in dispersions 
[117] and on solid substrates [118], thus giving the opportu-
nity to be easily manipulated for the creation of 3D biomate-
rials. 
Self-supporting hydrogels can be achieved through the 
rational manipulation of the colloidal interactions between 
solvated graphene sheets, by means of physisorption of acry-
lamide polymer chains onto pristine graphene sheets without 
any binders or cross-linkers [119]. The resulting thin mate-
rial has remarkable flexibility and adaptability [120]. Gra-
phene-based hydrogels can be obtained via a hydrothermal 
route, and display remarkable conductivity, mechanical 
strength, thermal stability and high specific capacitance 
[121]. This approach effectively delivers a 3D nanostruc-
tured material in one step, through entrapment of water me-
diated by hydrogen bonding with oxygenated functional 
groups on GO and partial establishment of π-stacking inter-
actions between GO sheets [121]. Supramolecular co-
assembly into hydrogels can also be obtained through elec-
trostatic interactions between a positively charged drug (e.g., 
metformin hydrochloride), and the carboxylate groups of 
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GO. Thanks to the cross-linking role played by the drug, the 
material displays pH-dependent drug release profiles [122]. 
Alternatively, one-step fabrication of macroscopic hydrogel 
monoliths can be achieved by means of reduction of GO 
sheets by ferrous ions and in situ simultaneous deposition of 
iron-based nanoparticles on graphene sheets [123]. 
 Preliminary studies over a 3-day period on GO hydrogel 
biocompatibility reveal a promising biomaterial performance 
as bone-derived cells are able to grow and protrude filopodia 
[124]. This kind of material has high potential for bone tis-
sue regeneration, thanks to its ability to stimulate osteogenic 
differentiation of stem cells, and to an overall good biocom-
patibility profile upon subcutaneous implantation into rats 
[125]. 
It seems unlikely that graphene-only hydrogels will make 
their way into the clinic, but we cannot exclude that they 
may be further developed to optimize their use as scaffold 
skeleton, realizing their electro-responsive behavior to 
achieve “smart” engineered tissues or drug delivery systems. 
6. CONCLUSION 
In conclusion, we have seen how nanostructured carbon 
has already been integrated with a wide variety of hydrogels 
for biomaterial applications, spanning from protein/peptides, 
through polysaccharides to synthetic polymers, for tissue 
engineering and on-demand drug release. The vast majority 
of these studies are still tackling basic research questions in 
vitro, with only a few attempting to address the issues asso-
ciated with more complex research models in vivo. Clearly, 
this is still a young, emerging area that poses many chal-
lenges to be addressed, for its realistic implementation into 
therapy. However, more and more medicinal chemists are 
being fascinated by the unique properties of nanocarbons, 
and it is only through the determined research efforts to 
make them more biocompatible, that novel therapeutic para-
digms can be realized to find credible solutions to unre-
solved therapeutic dilemmas. 
LIST OF ABBREVIATIONS 
CNT = carbon nanotube 
CS = chitosan 
DC = direct current 
Fmoc = fluorenylmethyloxycarbonyl 
GelMA = gelatin methacrylate 
GO = graphene oxide 
GSH = glutathione 
MWCNT = multi-wall carbon nanotube 
pAA = poly(acrylic acid) 
PEO = poly(ethylene) oxide 
Phe = Phenylalanine 
pMAA = poly(methacrylic acid) 
pNIPAAm = poly(N-isopropylacrylamide) 
PPO = poly(propylene) oxide 
PVA = poly(vinyl) alcohol 
RGD = Arginine-Glycine-Aspartic acid 
rGO = reduced graphene oxide  
SWCNT = single-wall carbon nanotube 
VEGF = vascular endothelial growth factor 
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